Clinical characteristics and predictors of delayed discharge among children with SARS‑CoV‑2 Omicron variant infection
- PMID: 38259584
- PMCID: PMC10801348
- DOI: 10.3892/br.2023.1717
Clinical characteristics and predictors of delayed discharge among children with SARS‑CoV‑2 Omicron variant infection
Abstract
The present study investigated the epidemiology and clinical characteristics of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant and determined the risk factors for delayed discharge or release from isolation for pediatric patients in Quanzhou, China in 2022. There were 145, 254 and 23 patients in the asymptomatic, mildly symptomatic and moderately symptomatic categories, respectively. The proportion of pediatric patients in the moderately symptomatic category increased with increasing age. No child aged <1 year and 9.02% of patients aged 13-18 years were in the moderately symptomatic category. The proportion of patients with asymptomatic infection did not differ significantly by vaccination status. The median days until the first negative conversion of viral RNA was 11 days, and the median hospitalization duration was 16 days. Most symptoms appeared in the upper respiratory tract. Notably, ~33.23% of patients showed elevated aspartate aminotransferase levels. C-reactive protein and interleukin-6 (IL-6) levels, and lymphocyte counts were consistently lower in asymptomatic patients than those in in symptomatic patients. Adjusted logistic regression analyses indicated that IL-6 levels and time to the first negative conversion of viral RNA were independent risk factors for delayed discharge. The area under the curve of the regression model for predicting delayed discharge was 0.760. In conclusion, these results could facilitate the formulation of global epidemic prevention policies for pediatric patients.
Keywords: children; clinical characteristics; delayed discharge; risk factors; severe acute respiratory syndrome coronavirus 2 Omicron variant.
Copyright: © Zheng et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Clinical and virological features of asymptomatic and mild symptomatic patients with SARS-CoV-2 Omicron infection at Shanghai Fangcang shelter hospital.Immun Inflamm Dis. 2023 Sep;11(9):e1033. doi: 10.1002/iid3.1033. Immun Inflamm Dis. 2023. PMID: 37773703 Free PMC article.
-
[Clinical features of severe acute respiratory syndrome coronavirus 2 Omicron variant infection in children: an analysis of 201 cases].Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jan 15;25(1):5-10. doi: 10.7499/j.issn.1008-8830.2207052. Zhongguo Dang Dai Er Ke Za Zhi. 2023. PMID: 36655657 Free PMC article. Chinese.
-
[Analysis of clinical characteristics and prognosis of 4 264 patients with asymptomatic and mild novel coronavirus infections in Shanghai].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 May;34(5):449-453. doi: 10.3760/cma.j.cn121430-20220516-00490. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35728842 Chinese.
-
[Clinical characteristics of children with SARS-CoV-2 Omicron variant infection in Kunming].Zhonghua Er Ke Za Zhi. 2023 Oct 2;61(10):922-927. doi: 10.3760/cma.j.cn112140-20230712-00448. Zhonghua Er Ke Za Zhi. 2023. PMID: 37803860 Chinese.
-
[Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Jan;35(1):32-36. doi: 10.3760/cma.j.cn121430-20220406-00339. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36880235 Chinese.
References
-
- WHO: COVID-19 Weekly Epidemiological Update (2022). Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on....
-
- CoVariants. Available from: https://covariants.org/. 2022.
-
- WHO: Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern 2022. Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1..... 2022.
-
- Jansen L, Tegomoh B, Lange K, Showalter K, Figliomeni J, Abdalhamid B, Iwen PC, Fauver J, Buss B, Donahue M. Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) variant cluster-Nebraska, November-December 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1782–1784. doi: 10.15585/mmwr.mm705152e3. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous